查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1716772

医疗外骨骼市场：按组件、类型、技术、功能、结构和最终用途划分－2025-2030 年全球预测

Medical Exoskeleton Market by Component, Type, Technology, Functionality, Structure, End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2024年医疗外骨骼市场价值将达到16.6亿美元，2025年将达到18.7亿美元，复合年增长率为12.78%，到2030年将达到34.2亿美元。

主要市场统计数据
基准年2024年 16.6亿美元
预计2025年 18.7亿美元
预测年份 2030 34.2亿美元
复合年增长率（%） 12.78%

医疗外骨骼正在改变现代医学的格局，为行动不便的患者带来新的希望并改善生活品质。这些先进的设备结合了尖端机器人技术、工程技术和数位整合技术，为復健、患者照护和日常活动提供了无与伦比的支援。医疗外骨骼的出现不仅代表着科技的进步；它代表着医疗保健向以病人为中心的根本转变。随着这些设备的有效性透过临床应用变得越来越明显，医疗保健提供者正在寻求综合的方法将它们整合到标准护理实践中。增强的功能和改善的患者治疗效果使这些系统在更广泛的医疗保健创新领域中占据重要地位。

本执行摘要旨在阐明医疗外骨骼市场的各个方面，从突破性的技术进步到告知市场趋势的策略性细分。透过探索新兴趋势、挑战和机会，相关人员可以获得实际的见解，了解这些变革性设备如何为患者照护树立新的标竿。透过对市场驱动因素、竞争动态和市场机会的详细分析，以下章节为理解医疗外骨骼如何不仅彻底改变患者照护，而且还重新定义临床、研究和商业应用的行业标准奠定了基础。

改变医疗外骨骼市场

医疗外骨骼市场的演变是由再形成产业技术、经济和监管格局的变革性变化所定义的。机器人和感测器技术的创新大大提高了这些系统的性能和功能，从而能够提供更精确、更适应的患者支援。先进的致动器、微控制器和感测器整合到硬体框架中，并配备复杂的控制和监控软体，正在加速从实验设备到商业性可行解决方案的转变。超越传统模式，新的通讯协定和设计不断涌现，以满足不同患者群体的不同需求，促进整体的行动援助方法。

此外，永续设计原则和成本优化策略指南产品开发。随着外骨骼技术的有效性在研究和临床试验中检验，市场正在涌入大量投资和伙伴关係。重新专注于创新设计不仅可以提高设备效能，而且为更灵活、更具成本效益的生产流程铺平了道路。协作研究努力和多学科方法实现了硬体和软体组件之间的动态相互作用，使得设备能够根据不同护理环境中的特定治疗、健身或操作需求进行客製化。在这种不断变化的情况下，营运商和医疗保健决策者越来越意识到这种转型转变的重要性，这种转变有望长期改善患者的治疗效果、员工安全和业务效率。

揭示市场动态的关键细分洞察

详细研究市场细分可以发现对于确定医疗外骨骼产业未来发展方向至关重要的焦点趋势。市场已从多个维度进行了研究，包括硬体和软体差异化因素。进一步分析硬体组件，包括致动器、微控制器和感测器，它们在确保精确运动和自适应性能方面发挥着至关重要的作用。同时，包括控制软体和监控软体在内的软体部分提供了必要的接口，以便于即时调整和以用户为中心的客製化。综合考虑这些方面，可以全面了解支援这些设备发展的技术支柱。

透过区分被动外骨骼和动力外骨骼，分割策略得到进一步扩展。这种差异强调了能量吸收支撑和功能性主动运动辅助之间的平衡，从而满足了广泛用户的需求。当考虑所使用的技术时，从电气、液压、机械和气动系统的研究中获得的见解揭示了广泛的设计可能性。每种技术方法都针对各种应用的效能进行了最佳化，确保设备在稳定性、效率和可靠性方面不仅满足而且超越传统的期望。

此外，基于功能的全身、下半身和上半身外骨骼分割突出了专门的设计如何满足不同的解剖或功能要求。透过结构组成分析，市场分为刚性外骨骼和软性外骨骼，每种类别在耐用性和舒适性方面都有独特的优势。最后，来自老年护理机构、家庭护理环境、军事和国防应用、研究机构和大学以及体育和健身环境等终端用途领域的见解揭示瞭如何定制这些设备以适应各种操作场景。这种多方面的方法不仅凸显了医疗外骨骼的多功能性，而且使产品开发与快速发展的市场的特定需求保持一致。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 更重视受伤后和手术后的康復
      • 人口老化和预期寿命延长需要高效的旅行和康復
      • 神经系统疾病和肌肉骨骼疾病盛行率不断上升
    • 限制因素
      • 医疗外骨骼的生产开发成本高
    • 机会
      • 增加对穿戴式外骨骼系统开发的投资和资金
      • 生物医学工程师与医疗保健专业人员进行早期疗育治疗新合作
    • 任务
      • 与严格的临床试验和全面的监管核准相关的担忧
  • 市场区隔分析
    • 组件：软体对于实现自适应运动控制演算法的重要性日益增加
    • 最终用途：扩大医疗外骨骼在老年护理机构的应用，以提高行动能力
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

6. 医疗外骨骼市场（按组件）

  • 硬体
    • 致动器
    • 微控制器
    • 感应器
  • 软体
    • 控制软体
    • 监控软体

第七章 医疗外骨骼市场（按类型）

  • 被动外骨骼
  • 动力外骨骼

8. 医疗外骨骼市场（依技术）

  • 电
  • 油压
  • 机器
  • 气压

第九章 医疗外骨骼市场（依功能）

  • 全身外骨骼
  • 下肢外骨骼
  • 上身外骨骼

第 10 章 医疗外骨骼市场结构分析

  • 刚性外骨骼
  • 软外骨骼

第 11 章 医疗外骨骼市场（依最终用途）

  • 养老设施
  • 居家照护环境
  • 军事和国防
  • 科学研究机构和大学
  • 运动与健身

12.美洲医疗外骨骼市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

13. 亚太地区医疗外骨骼市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

14.欧洲、中东和非洲医疗外骨骼市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • B-Temia Inc.
  • Comau SpA
  • Cyberdyne Inc.
  • Ekso Bionics Holdings Inc.
  • ExoAtlet, LLC
  • Focal Meditech BV
  • Honda Motor Co. Ltd.
  • Hyundai Motor Company
  • Levitate Technologies
  • Lockheed Martin Corporation
  • Mitsubishi Heavy Industries, Ltd.
  • Myomo, Inc.
  • Ottobock SE & Co. KGaA
  • P&S Mechanics Co., Ltd.
  • Panasonic Holdings Corporation
  • Parker Hannifin Corporation
  • ReWalk Robotics Ltd.
  • Rex Bionics Corporation
  • Roam Robotics
  • Toyota Motor Corporation
  • Trexo Robotics, Inc.
  • Wandercraft SAS
  • Yaskawa Electric Corporation
Product Code: MRR-3E32260F820F

The Medical Exoskeleton Market was valued at USD 1.66 billion in 2024 and is projected to grow to USD 1.87 billion in 2025, with a CAGR of 12.78%, reaching USD 3.42 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 1.66 billion
Estimated Year [2025] USD 1.87 billion
Forecast Year [2030] USD 3.42 billion
CAGR (%) 12.78%

Medical exoskeletons are transforming the landscape of modern medicine, offering renewed hope and improved quality of life for patients grappling with mobility challenges. These advanced devices, which combine cutting-edge robotics, engineering, and digital integration, provide unparalleled support in rehabilitation, patient care, and everyday mobility. The emergence of medical exoskeletons is not merely a technological evolution; it represents a fundamental shift toward a more patient-centric approach in healthcare. As the efficacy of these devices becomes increasingly evident through clinical applications, healthcare providers are exploring comprehensive ways to integrate them into standard care practices. Enhanced functionality and improved patient outcomes have positioned these systems as a critical aspect of the broader healthcare innovation narrative.

This executive summary intends to elucidate the myriad facets of the medical exoskeleton market-from groundbreaking technological advancements to the strategic segmentation that informs market trends. By examining the emerging trends, challenges, and opportunities, stakeholders are provided with actionable insights into how these transformative devices are setting new benchmarks in patient care. Through an in-depth analysis of market drivers, competitive dynamics, and regional opportunities, the following sections lay the groundwork for understanding how medical exoskeletons are not only revolutionizing patient care but also redefining industry standards across clinical, research, and commercial applications.

Transformative Shifts in the Medical Exoskeleton Landscape

The evolution of the medical exoskeleton market is defined by transformative shifts that are reshaping the industry's technological, economic, and regulatory landscape. Innovations in robotics and sensor technology have dramatically increased the performance and capability of these systems, enabling more precise and adaptive patient support. The integration of advanced actuators, microcontrollers, and sensors within hardware frameworks, accompanied by sophisticated control and monitoring software, has accelerated the transition from experimental devices to commercially viable solutions. Moving beyond traditional models, new protocols and designs have emerged that address the diverse needs of varied patient populations, thereby promoting an inclusive approach to mobility assistance.

Furthermore, sustainable design principles and cost-optimization strategies now guide product development. As research and clinical trials validate the effectiveness of exoskeleton technology, the market is witnessing an influx of investments and partnerships. This renewed focus on innovative design not only enhances device performance but also paves the way for a more agile and cost-efficient production process. Collaborative research initiatives and interdisciplinary approaches have enabled a dynamic interplay between the hardware and software components, ensuring that devices can be tailored to specific therapeutic, fitness, or operational needs across different care settings. In this evolving scenario, operators and healthcare decision-makers are increasingly aware of the importance of these transformative shifts, which promise to yield long-term improvements in patient outcomes, workforce safety, and operational efficiency.

Key Segmentation Insights Illuminating Market Dynamics

An in-depth review of market segmentation reveals focused trends that are pivotal in defining the future trajectory of the medical exoskeleton industry. The market is studied across multiple dimensions that include the differentiating elements of hardware and software. The hardware component is analyzed further to encompass actuators, microcontrollers, and sensors, which play crucial roles in ensuring precise movement and adaptive performance. In tandem, the software segment, which includes control software and monitoring software, provides the necessary interface that facilitates real-time adjustments and user-centered customization. Observing these aspects together creates a comprehensive view of the technological backbone that supports the evolution of these devices.

The segmentation strategy extends further by distinguishing between passive and powered exoskeletons. This differentiation underscores the balance between energy-absorbing support and functionally active movement assistance, thereby catering to a broad spectrum of user needs. When considering the technology used, insights derived from studying the electric, hydraulic, mechanical, and pneumatic systems reveal a vast arena of design possibilities. Each technological approach is optimized for performance across various applications, ensuring that devices not only meet but exceed conventional expectations for stability, efficiency, and reliability.

Moreover, segmentation based on functionality-comprising full body, lower body, and upper body exoskeletons-highlights how specialized designs serve distinct anatomical or functional requirements. An analysis of the structural composition divides the market into rigid and soft exoskeletons, with each category offering inherent advantages in terms of durability and comfort, respectively. Finally, insights from end-use segmentations, which cover elderly care facilities, homecare settings, military and defense applications, research institutions and universities, and sports and fitness environments, illuminate how these devices can be tailored to serve varying operational contexts. This multifaceted approach not only underscores the versatility of medical exoskeletons but also aligns product development with the specific demands of a rapidly evolving market.

Based on Component, market is studied across Hardware and Software. The Hardware is further studied across Actuators, Microcontrollers, and Sensors. The Software is further studied across Control Software and Monitoring Software.

Based on Type, market is studied across Passive Exoskeletons and Powered Exoskeletons.

Based on Technology, market is studied across Electric, Hydraulic, Mechanical, and Pneumatic.

Based on Functionality, market is studied across Full Body Exoskeletons, Lower Body Exoskeletons, and Upper Body Exoskeletons.

Based on Structure, market is studied across Rigid Exoskeletons and Soft Exoskeletons.

Based on End-Use, market is studied across Elderly Care Facilities, Homecare Settings, Military & Defense, Research Institutions & Universities, and Sports & Fitness.

Key Regional Insights Defining Market Expansion

A comprehensive analysis of regional insights reveals that the Americas continue to serve as a hotbed for innovation and high adoption rates of medical exoskeleton technology, driven by advanced healthcare infrastructure and strong investment in research and development. In parallel, the region encompassing Europe, the Middle East, and Africa is emerging as a fertile ground for exploratory initiatives and cross-border collaborations, which propel market growth through an amalgamation of traditional healthcare values and modern technological strides. Meanwhile, the Asia-Pacific region is rapidly gaining prominence due to favorable government policies, a robust manufacturing ecosystem, and increasing consumer awareness. This entire regional mosaic exemplifies not only the diversity of adoption dynamics but also the critical role that geographic, economic, and socio-cultural factors play in shaping the growth trajectory of the industry.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights and Market Competitiveness

An evaluation of key players within the medical exoskeleton sector reveals an industry marked by dynamic competitiveness and robust innovation. Prominent companies have each contributed unique advancements that underscore their commitment to integrating high-grade materials, precision engineering, and groundbreaking technological solutions. Industry frontrunners such as B-Temia Inc. and Comau S.p.A. have established themselves through innovative engineering and collaborative research, setting a strong benchmark for product reliability and performance. Cyberdyne Inc. and Ekso Bionics Holdings Inc. further illustrate market leadership by integrating advanced software systems that blend seamlessly with hardware-driven functionalities, enhancing the overall value proposition.

International giants including ExoAtlet, LLC and Focal Meditech BV have consistently extended their technological expertise by investing in research and development to address emerging patient needs. Honda Motor Co. Ltd. and Hyundai Motor Company have leveraged their industrial prowess into advancing exoskeleton technology, positioning themselves strategically as drivers of the evolution from concept to clinical application. Other significant industry contributors such as Levitate Technologies and Lockheed Martin Corporation, along with key players like Mitsubishi Heavy Industries, Ltd. and Myomo, Inc., have expanded the competitive landscape by focusing on both market diversification and adoption-centric innovation.

Additionally, companies like Ottobock SE & Co. KGaA, P&S Mechanics Co., Ltd., Panasonic Holdings Corporation, and Parker Hannifin Corporation have garnered recognized accolades for their consistent performance and creative engineering approaches. ReWalk Robotics Ltd. and Rex Bionics Corporation exemplify the merging of clinical research and practical application, while Roam Robotics, Toyota Motor Corporation, Trexo Robotics, Inc., Wandercraft S.A.S., and Yaskawa Electric Corporation continue to deliver solutions that challenge conventional norms. Collectively, these insights depict a market in steep ascent, characterized by fierce competition, rapid technological advancement, and an unwavering focus on improving patient quality of life.

The report delves into recent significant developments in the Medical Exoskeleton Market, highlighting leading vendors and their innovative profiles. These include B-Temia Inc., Comau S.p.A., Cyberdyne Inc., Ekso Bionics Holdings Inc., ExoAtlet, LLC, Focal Meditech BV, Honda Motor Co. Ltd., Hyundai Motor Company, Levitate Technologies, Lockheed Martin Corporation, Mitsubishi Heavy Industries, Ltd., Myomo, Inc., Ottobock SE & Co. KGaA, P&S Mechanics Co., Ltd., Panasonic Holdings Corporation, Parker Hannifin Corporation, ReWalk Robotics Ltd., Rex Bionics Corporation, Roam Robotics, Toyota Motor Corporation, Trexo Robotics, Inc., Wandercraft S.A.S., and Yaskawa Electric Corporation. Actionable Recommendations for Steering Industry Success

For industry leaders looking to make a significant impact in the burgeoning field of medical exoskeletons, a proactive approach based on actionable recommendations is paramount. The first recommendation is to invest strategically in research and development initiatives that foster innovations tailored to clinical and operational demands. Leaders should also design strategic partnerships that enhance product capabilities and foster cross-disciplinary innovation, ensuring that both hardware and software components remain at the cutting edge. It is crucial to monitor market trends continuously and adapt business strategies to align with evolving regulatory and technological landscapes.

In addition, companies should consider targeting untapped market segments by diversifying product portfolios to address specialized applications-whether the focus lies on full body, lower body, or upper body solutions. Emphasis should be placed on developing products that resonate with key end-use areas such as elderly care facilities, homecare settings, military and defense operations, academic research institutions, and sports and fitness centers. The incorporation of state-of-the-art technologies-ranging from electric to hydraulic, mechanical, and pneumatic systems-will further enhance the competitive advantage by broadening the spectrum of customization and performance.

Industry leaders must also adopt agile manufacturing models and lean operational practices that not only reduce production costs but also facilitate rapid scalability in response to market demands. Collaborative engagements with academic and research institutions can serve as a catalyst for innovative breakthroughs, while active participation in policy formulation and industry standards setting ensures that companies stay ahead of regulatory curves. Embracing these recommendations can not only optimize operational efficiency but also fortify a company's position as a trusted and forward-thinking authority in the medical exoskeleton space.

Conclusion: Embracing the Future of Medical Exoskeleton Innovations

In summary, the medical exoskeleton market is witnessing an era of profound technological innovations and strategic realignments. The key findings of this analysis underscore how advancements in hardware and software integration are paving the way for more effective and adaptive mobility solutions. The segmentation insights reveal a robust market structure that accommodates specialized designs, diverse technological applications, and varying end-use scenarios. Moreover, regional dynamics indicate that while the Americas lead in innovation, other regions are rapidly emerging as key contributors to market growth. Insights into competitive strategies further reflect a vibrant ecosystem where companies are continuously pushing the boundaries of what is achievable within this space.

It is clear that the future of medical exoskeletons is not only promising but is poised to redefine standards in mobility assistance, patient rehabilitation, and overall healthcare delivery. The comprehensive analysis provided here reaffirms the critical importance of innovation, strategic planning, and targeted market diversification. As the market continues to evolve, stakeholders must remain vigilant and adaptive, leveraging both technological advancements and market opportunities to drive sustained growth and enhance patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased focus on post-injury and post-surgical rehabilitation
      • 5.1.1.2. Aging population and rising life expectancy necessitating efficient mobility and rehabilitation
      • 5.1.1.3. Increasing prevalence of neurological and musculoskeletal disorders
    • 5.1.2. Restraints
      • 5.1.2.1. High production and development costs of medical exoskeletons
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investments and funding to develop wearable exoskeleton systems
      • 5.1.3.2. Emerging collaborations between biomedical engineers and healthcare professionals for early-stage intervention therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with robust clinical trials and comprehensive regulatory approvals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Growing significance of software for enabling adaptive movement control algorithms
    • 5.2.2. End-Use: Increasing adoption of medical exoskeleton in elderly care facilities to provide enhanced mobility
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Medical Exoskeleton Market, by Component

  • 6.1. Introduction
  • 6.2. Hardware
    • 6.2.1. Actuators
    • 6.2.2. Microcontrollers
    • 6.2.3. Sensors
  • 6.3. Software
    • 6.3.1. Control Software
    • 6.3.2. Monitoring Software

7. Medical Exoskeleton Market, by Type

  • 7.1. Introduction
  • 7.2. Passive Exoskeletons
  • 7.3. Powered Exoskeletons

8. Medical Exoskeleton Market, by Technology

  • 8.1. Introduction
  • 8.2. Electric
  • 8.3. Hydraulic
  • 8.4. Mechanical
  • 8.5. Pneumatic

9. Medical Exoskeleton Market, by Functionality

  • 9.1. Introduction
  • 9.2. Full Body Exoskeletons
  • 9.3. Lower Body Exoskeletons
  • 9.4. Upper Body Exoskeletons

10. Medical Exoskeleton Market, by Structure

  • 10.1. Introduction
  • 10.2. Rigid Exoskeletons
  • 10.3. Soft Exoskeletons

11. Medical Exoskeleton Market, by End-Use

  • 11.1. Introduction
  • 11.2. Elderly Care Facilities
  • 11.3. Homecare Settings
  • 11.4. Military & Defense
  • 11.5. Research Institutions & Universities
  • 11.6. Sports & Fitness

12. Americas Medical Exoskeleton Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Medical Exoskeleton Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Medical Exoskeleton Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Wandercraft's clinical trial validates natural, hands-free walking restoration for spinal cord injury rehabilitation supporting market expansion
    • 15.3.2. Innophys launches its Muscle Suit in Singapore to boost worker safety and productivity across healthcare, caregiving, and industrial sectors
    • 15.3.3. IIT Kanpur's launch of groundbreaking BCI-based robotic hand exoskeleton with closed-loop EEG control transforms stroke rehabilitation
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. B-Temia Inc.
  • 2. Comau S.p.A.
  • 3. Cyberdyne Inc.
  • 4. Ekso Bionics Holdings Inc.
  • 5. ExoAtlet, LLC
  • 6. Focal Meditech BV
  • 7. Honda Motor Co. Ltd.
  • 8. Hyundai Motor Company
  • 9. Levitate Technologies
  • 10. Lockheed Martin Corporation
  • 11. Mitsubishi Heavy Industries, Ltd.
  • 12. Myomo, Inc.
  • 13. Ottobock SE & Co. KGaA
  • 14. P&S Mechanics Co., Ltd.
  • 15. Panasonic Holdings Corporation
  • 16. Parker Hannifin Corporation
  • 17. ReWalk Robotics Ltd.
  • 18. Rex Bionics Corporation
  • 19. Roam Robotics
  • 20. Toyota Motor Corporation
  • 21. Trexo Robotics, Inc.
  • 22. Wandercraft S.A.S.
  • 23. Yaskawa Electric Corporation

LIST OF FIGURES

  • FIGURE 1. MEDICAL EXOSKELETON MARKET MULTI-CURRENCY
  • FIGURE 2. MEDICAL EXOSKELETON MARKET MULTI-LANGUAGE
  • FIGURE 3. MEDICAL EXOSKELETON MARKET RESEARCH PROCESS
  • FIGURE 4. MEDICAL EXOSKELETON MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2024 VS 2030 (%)
  • FIGURE 19. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 23. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 28. MEDICAL EXOSKELETON MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 29. MEDICAL EXOSKELETON MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MEDICAL EXOSKELETON MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MEDICAL EXOSKELETON MARKET DYNAMICS
  • TABLE 7. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ACTUATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MICROCONTROLLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SENSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY CONTROL SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MONITORING SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY PASSIVE EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY POWERED EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ELECTRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY HYDRAULIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY PNEUMATIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY RIGID EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SOFT EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ELDERLY CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MILITARY & DEFENSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY RESEARCH INSTITUTIONS & UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SPORTS & FITNESS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. INDONESIA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. JAPAN MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 130. JAPAN MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 131. JAPAN MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 132. JAPAN MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. MALAYSIA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 138. MALAYSIA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 139. MALAYSIA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 140. MALAYSIA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. PHILIPPINES MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 146. PHILIPPINES MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 148. PHILIPPINES MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. SINGAPORE MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 154. SINGAPORE MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 155. SINGAPORE MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 156. SINGAPORE MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH KOREA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH KOREA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH KOREA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 169. TAIWAN MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 170. TAIWAN MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 171. TAIWAN MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 172. TAIWAN MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 177. THAILAND MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 178. THAILAND MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 179. THAILAND MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 180. THAILAND MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. VIETNAM MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 186. VIETNAM MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 187. VIETNAM MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 188. VIETNAM MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 202. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 203. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 204. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 205. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 210. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 211. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 212. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 213. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 218. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 219. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 220. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 221. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 226. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 227. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 228. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 229. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 234. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 235. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 236. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 237. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 242. ISRAEL MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 243. ISRAEL MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 244. ISRAEL MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 245. ISRAEL MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 250. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 251. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 252. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 253. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 258. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 260. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 266. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 267. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 268. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 269. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 274. NORWAY MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 275. NORWAY MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 276. NORWAY MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 277. NORWAY MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 282. POLAND MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 283. POLAND MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 284. POLAND MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 285. POLAND MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 290. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 291. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 292. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 293. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 298. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 299. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 300. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 301. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 306. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 307. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 308. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 314. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 315. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 316. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 322. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 323. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 324. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 325. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 326. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 328. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 330. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 331. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 332. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 333. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 334. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 335. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 336. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 337. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 338. SWITZERLAND MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 339. SWITZERLAND MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 340. SWITZERLAND MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 342. SWITZERLAND MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 344. SWITZERLAND MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 346. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 347. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 348. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 349. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 350. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 351. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 352. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 353. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 354. UNITED ARAB EMIRATES MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 355. UNITED ARAB EMIRATES MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 356. UNITED ARAB EMIRATES MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 357. UNITED ARAB EMIRATES MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 358. UNITED ARAB EMIRATES MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 359. UNITED ARAB EMIRATES MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 360.